R. Ozaras Et Al. , "First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment," EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7, pp.774-780, 2014
Ozaras, R. Et Al. 2014. First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7 , 774-780.
Ozaras, R., Mete, B., Ceylan, B., Ozgunes, N., Gunduz, A., Karaosmanoglu, H., ... Cagatay, A.(2014). First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7, 774-780.
Ozaras, Reşat Et Al. "First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment," EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7, 774-780, 2014
Ozaras, Reşat Et Al. "First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7, pp.774-780, 2014
Ozaras, R. Et Al. (2014) . "First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.26, no.7, pp.774-780.
@article{article, author={Reşat ÖZARAS Et Al. }, title={First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment}, journal={EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY}, year=2014, pages={774-780} }